About 6 results found for searched term "555-55-5" (0.12 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M7837 | Hispidin | PKC |
| Hispidin is a potent inhibitor of protein kinase Cβ, cytotoxic for cancer cells. | ||
| M10047 | Dorzagliatin | Glucokinase (GK) |
| HMS5552; RO5305552; Sinogliatin | ||
| Dorzagliatin (HMS-5552, RO-5305552, Sinogliatin) is a glucokinase (GK) activator, which improves glycaemic control and pancreatic β-cell function for type 2 diabetes. | ||
| M6887 | L755507 | Adrenergic Receptor |
| L-755,507 | ||
| L755507 is a potent, selective agonist of β3-AR with an IC50 of 35 nM. L755507 enhances the homology-directed repair (HDR)-mediated genome editing in CRISPR/Cas9 nickase system. | ||
| M20984 | Varenicline dihydrochloride | AChR/AChE |
| Chantix, Champix | ||
| Varenicline (CP 526555, Chantix, Champix) dihydrochloride is a potent, partial agonist of α4β2 nicotinic acetylcholine receptor (nAChR) and α3β4 nAChR with EC50 of 2.3 μM and 55 μM, respectively. Varenicline dihydrochloride is a potent, full agonist of α7 nAChRs with EC50 of 18 μM. Varenicline is a prescription medication used for smoking cessation. | ||
| M28302 | SR1555 | ROR |
| SR1555 is a specific retinoic acid receptor-related orphan nuclear receptor γ (RORγ) inverse agonist with an IC50 value of 1 μM. SR1555 not only inhibits TH17 cell development and function but also increases the frequency of T regulatory cells, as well as inhibits the expression of IL-17. SR1555 can be used for researching autoimmune diseases. | ||
| M45142 | Vari Fluor 555 SE | Fluorescent Dye |
| VF 555 SE | ||
| Vari Fluor 555 SE is a Vari Fluor SE series labeling dye (Ex/Em=550 nm/561 nm).The Vari Fluor SE series dyes are a class of fluorescent dyes that contain NHS ester groups for labeling antibodies, proteins, peptides, amine-modified oligonucleotides, and free amines (-NHX) on other biomolecules. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
